38 results
8-K
EX-99.1
BXRXQ
Baudax Bio, Inc.
6 Oct 23
Departure of Directors or Certain Officers
8:00am
Engineering culture reagents cytokines Treg stabilizer Plus Proprietary Technology 5 Freezing/ Packaging Infusion 6 IP Protected and FDA IND cleared
PRER14A
BXRXQ
Baudax Bio, Inc.
25 Aug 23
Preliminary revised proxy
4:01pm
things, the research, development, testing, manufacture, quality control, approval, labeling, packaging, storage, record-keeping, promotion, advertising … . Additionally, appropriate packaging must be selected and tested, and stability studies must be conducted to demonstrate that the product candidate does
DEFA14A
EX-99.1
lnns3akg3kq9s9bg6 gl
9 Aug 23
Additional proxy soliciting materials
5:28pm
8-K/A
EX-99.1
k650a8o9spjge4zn
9 Aug 23
Other Events
5:27pm
DEFA14A
td9nig7fxrea9i10p
17 Jul 23
Additional proxy soliciting materials
7:05am
8-K
EX-99.1
1nhqpzl dh
17 Jul 23
Other Events
7:00am
8-K/A
EX-10.3
y7whyxb4k34tjax
4 Apr 23
Entry into a Material Definitive Agreement
4:09pm
8-K
EX-10.1
h8bq8s2
2 Jun 20
Entry into a Material Definitive Agreement
7:45am
10-K
EX-10.29
kle1rzn01nd1110
13 Feb 20
Annual report
5:05pm
10-K
m5d3ccu1jt6z0o2 uhl
13 Feb 20
Annual report
5:05pm
8-K
EX-99.1
n97s1xhhd
26 Nov 19
Entry into a Material Definitive Agreement
4:53pm
10-12B/A
EX-99.1
8k5 2c2l722c
8 Nov 19
Registration of securities (amended)
4:42pm
10-12B/A
EX-99.1
yee19go8b483pl0
5 Nov 19
Registration of securities (amended)
12:16pm
10-12B
EX-10.10
vqy0fmp491e9v68i
22 Oct 19
Registration of securities
5:16pm